Last reviewed · How we verify
NCT03902301: ProjectPCOS
Lactobacillus Rhamnosus and PCOS Treatment
NA trial testing Lactobacillus group in Insulin Resistance in 80 participants. Completed in 31 December 2020.
31 December 2020
Quick facts
| Lead sponsor | Poznan University of Life Sciences |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 1 April 2018 |
| Primary completion | 31 December 2020 |
| Estimated completion | 31 December 2020 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- Lactobacillus group
- Dietary group
Conditions studied
- Insulin Resistance — all drugs for Insulin Resistance →
- Polycystic Ovary Syndrome — all drugs for Polycystic Ovary Syndrome →
- Hyperandrogenism — all drugs for Hyperandrogenism →
- Obesity — all drugs for Obesity →
Sponsor
Poznan University of Life Sciences
Who can join
Adults 18 to 40, female only, with Insulin Resistance or Polycystic Ovary Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The effect of Lactobacillus rhamnosus supplementation on body weight, hyperandrogenism and insulin resistance in overweight and obesity women with Polycystic Ovary Syndrome will be analysed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03902301
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Insulin Resistance
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07226128 — The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV · NA · recruiting
- NCT07505745 — MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity · Phase 2 · recruiting
- NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen · NA · recruiting
- NCT06768827 — New Mechanisms of Obesity · NA · recruiting
Other Poznan University of Life Sciences trials
Trials by the same sponsor.
- NCT07245979 — Supplementation With Sirtuin Activators in Women With Increased Body Weight · NA · recruiting
- NCT06677411 — Vitamin D Status Fluctuations Over One Academic Year in Students · active not recruiting
- NCT06344377 — Betaine Supplementation and Lipid Metabolism in Overweight and Obese Pre-menopausal Women · NA · completed
- NCT06239363 — Dietary Salicylates and Preeclampsia · recruiting
- NCT06860581 — The Impact of Selected Probiotic Bacteria on Gut Microbiota, Stress Indicators and Nutritional Status of Young Adults · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03902301 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Poznan University of Life Sciences
- Last refreshed: 26 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03902301.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing